The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A comparison of carboplatin with paclitaxel and cisplatinum with 5-fluorouracil in definitive chemoradiotherapy in esophageal cancer patients.
Judith Honing
No relevant relationships to disclose
Justin Smit
No relevant relationships to disclose
Christina Muijs
No relevant relationships to disclose
Johannes Burgerhof
No relevant relationships to disclose
Jannet Beukema
No relevant relationships to disclose
John Theodorus Plukker
No relevant relationships to disclose
Geke Hospers
No relevant relationships to disclose